Humacyte is trading up 5.69% at $0.42 as of 11:43 a.m. EST on November 6, amid a broader market rebound; the stock-specific cause is unconfirmed.

  • The Nasdaq is up 1.65% as markets rebound after the previous session’s sell-off.
  • Humacyte’s third-quarter results and business update are scheduled for November 10.